Does inhaled nitric oxide therapy improve acute severe right heart failure associated with pulmonary hypertension?
The PHiNO study is a Phase 2 protocol designed to evaluate the efficacy and safety of inhaled nitric oxide therapy for rapidly improving acute severe right heart failure associated with pulmonary hypertension.
iNO therapy is expected to play a significant role in rapidly improving acute severe RHF associated with PH.
Ueda et al. (Mon,) studied this question.